AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,587,783 | +4.6% | 19,724 | +3.7% | 0.06% | +30.0% |
| Q1 2024 | $1,518,355 | +39.9% | 19,027 | +39.5% | 0.05% | -3.8% |
| Q4 2023 | $1,085,687 | +9.8% | 13,641 | -3.6% | 0.05% | +2.0% |
| Q3 2023 | $988,804 | -21.9% | 14,148 | -19.7% | 0.05% | -17.7% |
| Q2 2023 | $1,265,886 | +8.9% | 17,616 | -6.5% | 0.06% | +5.1% |
| Q1 2023 | $1,162,421 | -20.4% | 18,846 | -0.4% | 0.06% | -23.4% |
| Q4 2022 | $1,459,762 | +120.2% | 18,926 | +27.3% | 0.08% | +102.6% |
| Q3 2022 | $663,000 | -0.9% | 14,865 | -14.9% | 0.04% | +11.8% |
| Q2 2022 | $669,000 | +1.1% | 17,474 | +9.2% | 0.03% | +9.7% |
| Q1 2022 | $662,000 | -10.7% | 16,006 | -18.4% | 0.03% | -3.1% |
| Q4 2021 | $741,000 | -26.0% | 19,619 | -35.4% | 0.03% | -28.9% |
| Q3 2021 | $1,001,000 | -25.2% | 30,375 | +53.0% | 0.04% | -23.7% |
| Q2 2021 | $1,339,000 | +28.9% | 19,848 | +8.2% | 0.06% | +22.9% |
| Q1 2021 | $1,039,000 | – | 18,342 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 991,754 | $58,345,000 | 37.79% |
| VR Adviser, LLC | 810,000 | $47,652,000 | 12.91% |
| ACUTA CAPITAL PARTNERS, LLC | 308,500 | $18,149,000 | 8.80% |
| Fairmount Funds Management LLC | 189,598 | $11,154,000 | 6.76% |
| RA Capital Management | 1,904,094 | $112,018,000 | 3.54% |
| Ghost Tree Capital, LLC | 215,000 | $12,648,000 | 3.36% |
| MORGAN JESS S & CO INC | 42,402 | $2,495,000 | 3.24% |
| RTW INVESTMENTS, LP | 1,052,969 | $61,946,000 | 2.67% |
| EAM Global Investors LLC | 50,649 | $2,980,000 | 1.74% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,172,014 | $68,950,000 | 1.67% |